WEHI researchers using stem cells to prevent diabetes
09 May, 2003 by Melissa TrudingerResearchers at the Walter and Eliza Hall Institute are devising a stem-cell-based approach designed to prevent the development of type 1 diabetes in susceptible individuals by engineering the haematopoietic stem cells to express proinsulin after differentiation into antigen presenting cells.
Malaria vaccine delivers unexpected bonus to Prima
07 May, 2003 by Melissa TrudingerPrima BioMed subsidiary PanVax and researchers at the Austin Research Institute have demonstrated that a malaria vaccine developed using its DCtag adjuvant technology is able to eradicate established disease in mice infected with malaria.
HIV study returns good results for Biota technology
30 April, 2003 by Pete YoungImpressive US test results which indicate the effectiveness of a potential anti-HIV/AIDS drug is generating good news on three levels for anti-viral specialist Biota Holdings.
AustCancer ditches its mining past
24 April, 2003 by Jeremy TorrAnother West Australian ex-mining listing has finally shaken off the last vestiges of mineral exploration and turned completely to the world of biotech.
GTG appointments expected to boost test service
22 April, 2003 by Melissa TrudingerMelbourne biotechnology company Genetic Technologies (ASX: GTG) has appointed two Australian scientists to assist it with the set up of its new cancer susceptibility genetic testing service.
BresaGen soars on Parkinson's results
14 April, 2003 by Melissa TrudingerAustralian stem cell company BresaGen has demonstrated functional recovery from the effects of Parkinson's disease in a rat model treated with human dopaminergic neurons derived from human embryonic stem cells.
Singapore: report slams non-ethical research practices, director fired
09 April, 2003 by Kate WebsterSingapore's efforts to become a global hub for the biomedical sciences faced its first major hurdle last week with the sacking of world-renowned British neurologist, Dr Simon Shorvon, from his post as the director of the National Neuroscience Institute.
Study backs theory that TB jab could guard against asthma
07 April, 2003 by Graeme O'NeillA Sydney epidemiological study has given further weight to a theory that exposure to non-viral respiratory infections in childhood may protect against asthma later in life.
The research road to doctorate
27 March, 2003 by Graeme O'NeillWorking hard for low pay, but Graeme O'Neill reports that the pursuit of a PhD could be the most rewarding time in a scientist's life.
US firm claims Vision Bio infringed patents
26 March, 2003 by Melissa TrudingerA legal battle has erupted over Vision BioSystems' new cancer detection instruments, with US company Ventana Medical Systems filing claims alleging patent infringement in a US court last week.
Prana teams with NSV, Schering
24 March, 2003 by Melissa TrudingerMelbourne company Prana Biotechnology has announced an agreement with Neurosciences Victoria and German pharma Schering worth up to $AUD7.5 million over the next three to five years.
CSIRO fields cancer diagnosis tools
20 March, 2003 by Jeremy TorrCSIRO Bioinformatics, a spin-off company from CSIRO Mathematical and Information Sciences, has developed new statistical methods it says could lead to improved diagnosis and treatment of cancers.
Starpharma gel wards off retrovirus infection
19 March, 2003 by Graeme O'NeillMelbourne nano-biotech company Starpharma Pooled Development (ASX:SPL) announced today that tests in the US have shown that its lead compound, a intravaginal gel developed to protect against sexually transmitted diseases, is completely effective in warding off an HIV-like retrovirus infection in macaque monkeys.
World on alert as unidentified pneumonia strikes
17 March, 2003 by Graeme O'NeillInternational health authorities have gone on high alert as more reports emerge from south-east Asian countries of deaths and illness caused by an unidentified, potentially lethal pneumonia-like infection dubbed Hong Kong severe acute respiratory syndrome.
Prana chief wins award
17 March, 2003 by Graeme O'NeillThe American Academy of Neurology has given its 2003 Potamkin Award for research into Alzheimer's disease to Dr Ashley Bush, co-founder of Melbourne biotechnology company Prana Biotechnology (ASX: PBT).
